Roundhill GLP-1与减肥主动型ETF OZEM 深 沪
已收盘 02-06 16:00:00 美东时间
35.00
+1.600
+4.79%
华盛通- 最 高35.00
- 今 开34.52
- 成交量 1.41万股
- 最 低 34.37
- 昨 收 33.40
- 总市值 5845.00万
- 52周最高 37.15
- 市盈率 静 --
- 换手率 0.85%
- 52周最低 19.6001
- 委 比 60.00%
- 总股本 167.00万
- 历史最高 37.15
- 量 比 0.23
- 振 幅 1.89%
- 历史最低 19.6001
- 每 手 1
- 风险率 4.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多EXCLUSIVE: Trump 'Amplified' Several Investing Themes – ETF CEO Picks 3 Sectors Benefitting The Most
President Donald Trump may be creating investment opportunities in themes and helping put an emphasize thematic ETFs.
01-28 06:05
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk
Novo's trial setback tests GLP-1-heavy ETFs, highlighting concentration risks while Eli Lilly's diversified pipeline offers relative resilience.
2025-11-25 01:06
华盛早报 | 外资又来唱多！大摩称中国股市有望继续上涨；美联储12月降息概率再降至43%
外资又来唱多！大摩称中国股市有望继续上涨；美联储12月降息概率一降再降，现已接近40%；拼多多、小米集团今日发财报>>
2025-11-18 08:23
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain
As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush.
2025-10-31 04:04
BRIEF-Novo Nordisk Says US FDA Approves Ozempic To Reduce Risk Of Worsening Kidney Disease
Jan 28 (Reuters) - Novo Nordisk A/S NOVOb.CO: FDA APPROVES OZEMPIC® (SEMAGLUTIDE) AS THE ONLY GLP-1 RA TO REDUCE THE RISK OF WORSENING KIDNEY DISEASE AND CARDIOVASCULAR DEATH IN ADULTS WITH TYPE 2 DIA...
2025-01-29 03:28
BRIEF-U.S. Govt Says Medicare Chose 15 More Drugs To Negotiate With Participating Drug Companies
Jan 17 (Reuters) - U.S. Government: US GOVERNMENT SAYS MEDICARE SELECTED 15 MORE DRUGS TO NEGOTIATE DIRECTLY WITH PARTICIPATING DRUG COMPANIES - WEBSITE U.S. SAYS SELECTED DRUG LIST FOR SECOND CYCLE O...
2025-01-17 21:03
美股GLP-1主题基金引发思考 下一个“诺和诺德”会是谁？
①上周上市的GLP-1主题基金不仅配置了诺和诺德、礼来等一众知名美股，也对港股、日股、欧股有所涉猎；②ETF发行商认为，减肥药市场有很大的增长空间，足以让更多的公司进入。
2024-05-28 07:25
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next
Weight loss drugs get the new parody treatment in a "South Park" streaming special.
2024-05-24 07:02
Roundhill Investments Launches GLP-1 & Weight Loss ETF (OZEM)
OZEM provides exposure to the rapidly growing weight loss management market, which is expected to reach $100 billion by 2030. NEW YORK, May 21, 2024 /PRNewswire/ -- Roundhill Investments, an...
2024-05-21 21:00
